AM
AMPH
Market ClosedAmphastar Pharmaceuticals, Inc.
US
1.98K employees
CEO: Yongfeng Zhang
Founded: 2014
$18.72
+$0.00(+NaN%)
Market Cap
825.42M
Beta
0.89
52W Range
N/A
Dividend Yield
1.60%
Forecasting Analysis
AI-powered predictions and statistical risk modeling for short-term price movements
AI Insight:
The AI short-term forecast is trending strongly downside, indicating near-term risk. Analyst consensus projects modest upside with strong coverage and a tight, broadly aligned range, reflecting relative agreement on longer-term potential. This contrast suggests short-term volatility amid stable longer-term expectations.
Current Price
N/A
Last closing price
Price Prediction
Machine learning prediction based on historical price patterns
Period:
Analyst Price Target for AMPH
Loading analyst price targets...
Wall Street Forecasts
Revenue Forecast
Past Growth
N/A
Based on Historical CAGR
Forward Growth
N/A
Projected CAGR
Analyst Accuracy
0%
Estimate Accuracy
Revenue Analysis
Comparison of Actual and Estimated Revenues
Loading chart data...
Revenue growth steady at 0.0%.
Operating Profitability Forecast
Past Growth
N/A
EBITDA Historical CAGR
Forward Growth
N/A
EBITDA Projected CAGR
Analyst Accuracy
0%
Estimate Accuracy
EBITDA Analysis
Comparison of Actual and Estimated EBITDA
Loading chart data...
EBITDA maintaining 0.0% trajectory.
Earnings Per Share Forecast
Past Growth
N/A
EPS Historical CAGR
Forward Growth
N/A
EPS Projected CAGR
Analyst Accuracy
0%
Estimate Accuracy
EPS Analysis
Comparison of Actual and Estimated Earnings Per Share
Loading chart data...
EPS growth stable around 0.0%.
Explore AMPH
AMPH in the Healthcare
Small Cap